Clinical trial
Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma
NCT00169468 · Lymphoma Study Association, Other · Completed
Key facts
| NCT number | NCT00169468 |
|---|---|
| Title | Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma |
| Official title | Phase II Study of the Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma |
| Lead sponsor | Lymphoma Study Association, Other |
| Collaborators | Association pour le Développement de la Recherche Clinique et Informatique en Onco-Hématologie |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | B Cell Lymphoma |
| Intervention type | Drug |
| Interventions | Rituximab -CHOP plus Velcade |
| Enrollment | 48 |
| Start date | Jan 1, 2005 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Aug 23, 2018 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: